Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva - Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual

Source: FDA | Recall date: 06/03/2026

Don't want to manually check every recall?

Track your baby products and get automatic recall alerts when something may affect your family.

Start Free Recall Tracking How Tracking Works

Learn more about the baby product recall tracker, automatic email item adding, or recall monitoring plans.

Affected product: Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva

Summary: Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.

Hazard: Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.

Open Official Recall Notice Back to Home

Don't want to manually check every recall?

Track your baby products and get automatic recall alerts when something may affect your family.

Start Free Recall Tracking How Tracking Works

Learn more about the baby product recall tracker, automatic email item adding, or recall monitoring plans.